Found: 5
Select item for more details and to access through your institution.
Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 9, p. 2190, doi. 10.1002/1878-0261.12697
- By:
- Publication type:
- Article
EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Targeting NPL4 via drug repositioning using disulfiram for the treatment of clear cell renal cell carcinoma.
- Published in:
- PLoS ONE, 2020, v. 15, n. 7, p. 1, doi. 10.1371/journal.pone.0236119
- By:
- Publication type:
- Article
Oncogenic effects of RAB27B through exosome independent function in renal cell carcinoma including sunitinib-resistant.
- Published in:
- PLoS ONE, 2020, v. 15, n. 5, p. 1, doi. 10.1371/journal.pone.0232545
- By:
- Publication type:
- Article
Potential new therapy of Rapalink‐1, a new generation mammalian target of rapamycin inhibitor, against sunitinib‐resistant renal cell carcinoma.
- Published in:
- Cancer Science, 2020, v. 111, n. 5, p. 1607, doi. 10.1111/cas.14395
- By:
- Publication type:
- Article